Immuneel Therapeutics
PrivateLast Round
Series B
Jun 8, 2026
Est. Valuation
$71M
Total Funding Raised
$52.65M
Company Overview
Immuneel Therapeutics is a biotechnology company that develops affordable cell and gene therapies, including CAR-T therapies, for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Lending & Credit
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuneel Therapeutics Comparables
Compare Immuneel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoACT | 89% | |
| Cellogen Therapeutics | 85% | |
| AbelZeta Pharma | 78% | |
Immuneel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2026 | ||||
| Grant | Jun 10, 2025 | ||||
| Series A Extension | Jul 10, 2024 | ||||
| Series A | Jun 21, 2022 | ||||
| Seed | Jan 8, 2020 |
Key People
Founding team and executive leadership
Immuneel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rainmatter Capital Fund | Series B |
| F-Prime Capital | Series A, Seed |
| Eight Roads Ventures | Series B, Series A, Seed |
| Singularity AMC | Series B |
| F-Prime Capital | Series B, Series A |
| True North | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Partnered with healthcare lending marketplace CarePal Money.
- Jan 8, 2026
Partnered with Impact Guru, a healthcare crowdfunding platform.
Immuneel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immuneel Therapeutics's valuation, stock price, and market status.